75.5 F
New York
Monday, September 28, 2020

vTv Therapeutics Inc. (NASDAQ:VTVT) Finding Strong Support

Must read

InspireMD Inc. (AMEX:NSPR) is Waving the Bull Flag

InspireMD Inc. (NSPR) shares are trading at higher $0.30. To add more color to this target, the company’s high over the last year is...

Quest Diagnostics Incorporated (NYSE:DGX) Stock is Soaring, Here is Why

Quest Diagnostics Incorporated (DGX) shares are trading at higher $111.70 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Renewed Optimism is Surrounding The GEO Group Inc. (NYSE:GEO)

The GEO Group Inc. (GEO) shares are trading at higher $10.98 and the avg recommendation for the stock is Moderate Buy, while the current...

The Rejuvenation of Palo Alto Networks Inc. (NYSE:PANW)

Palo Alto Networks Inc. (PANW) shares are trading at higher $242.14 and the avg recommendation for the stock is Strong Buy, while the current...

The vTv Therapeutics Inc. (VTVT) shares are trading at higher $2.98 and the avg recommendation for the stock is Moderate Buy.

To add more color to this target, the company’s high over the last year is $4.23 and the low is $1.23. Over the last 52 weeks, VTVT is down -29.55% while the S&P 500 is up 0.73%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, VTVT reported a profit of $6.65 million. vTv Therapeutics Inc. also saw revenues increase to $8000.0. In addition, VTVT has free cash flow of -$5.56 million as of 03-2020. The company’s EBITDA came in at -$6.57 million which compares well with its peers.

VTVT Return on Equity (ROE) is 32.20%, and its Return on Assets is -192.30%. All told, it is clear that, VTVT needs to be on your watchlist.

Find out when VTVT reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. VTVT has a short ratio of 4.32 and outstanding shares of 43.46M.

Company Outlook

VTVT has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.23 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.47. vTv Therapeutics Inc. VTVT also noted assets of $7.39 million at the end of the last quarter. Investors should also keep an eye on sector updates as VTVT has historically followed its peers on positive news.

All told, vTv Therapeutics Inc. VTVT has strung together solid data and demonstrated underlying fundamentals. At its current valuation, VTVT represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

vTv Therapeutics Inc. VTVT is now commanding a market cap of 211.55M and a float of 9.80M. VTVT is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of VTVT stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in VTVT, either long or short, and we have not been compensated for this article.

Latest article

Option Care Health Inc. (NASDAQ:OPCH) Stock is Soaring, Here is Why

Option Care Health Inc. (OPCH) shares are trading at higher $12.67 and the avg recommendation for the stock is Strong Buy, while the current...

United Natural Foods Inc. (NYSE:UNFI) is Holding Steady

United Natural Foods Inc. (UNFI) shares are trading at higher $17.91 and the avg recommendation for the stock is Moderate Buy, while the current...

Investor Confidence is Rising for TELUS Corporation (NYSE:TU)

TELUS Corporation (TU) shares are trading at higher $17.80. To add more color to this target, the company’s high over the last year is...

DBV Technologies S.A. (NASDAQ:DBVT) is Gaining Momentum on Earnings Catalyst

DBV Technologies S.A. (DBVT) shares are trading at higher $1.60 and the avg recommendation for the stock is Moderate Buy. To add more color...

The Rejuvenation of Orchard Therapeutics plc (NASDAQ:ORTX)

Orchard Therapeutics plc (ORTX) shares are trading at lower $4.42 and the avg recommendation for the stock is Strong Buy. To add more color...